{"disease":{"id":"biosensors","name":"biosensors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02625285","title":"Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04585568","title":"Validation of Ballistocardiographic Biosensors and Other Hemodynamic Measures for Healthy Subjects","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Oslo University Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}